3 Dirty Secrets Bay Street Doesn’t Want You to Know

Be wary of what Bay Street bankers and analysts tell you, especially when they tout stocks such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

| More on:
The Motley Fool
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Canada’s largest banks care about one thing and one thing only–maximizing profits for shareholders.

This isn’t necessarily bad, of course. Canada’s banks have made countless investors wealthy while providing a much-needed service for the economy. Ask the average mortgage holder if they hate their bank and the answer will probably be no. Sure, they’d like to be debt free, but a mortgage is a business deal that benefits both sides.

At the same time, folks have to be wary that their bank isn’t taking advantage of them. Small fees like overdraft interest and monthly banking packages might not seem like much, but they can add up to hundreds of dollars over the course of a year. These kinds of fees matter.

That’s not the only thing regular folks have to worry about. Here are three other ways their bank (or investment advisor) can take them for a ride.

You don’t need funds … or even ETFs

While there are a few mutual funds that have done quite well over the long term, for the most part investing in mutual funds is a sucker’s game. They just can’t do well enough to justify their outrageous fees.

ETFs are a lot better. They offer the same kind of diversification as mutual funds for a fraction of the cost. Most funds have fees of less than 0.5%, and it isn’t particularly hard to find one with a fee of less than 0.1%.

That works out to $1 in annual fees for every $1,000 invested. A mutual fund charging 2% would charge $20 for every $1,000 invested. That’s a huge difference.

But ETF fees can add up too. Say you have $100,000 invested in a portfolio of ETFs that have an average management fee of 0.3%. That’s $300 in annual fees.

Investors can save those annual fees by building a portfolio of great stocks that they intend to hold over the long term. One such stock is Inter Pipeline Ltd. (TSX:IPL).

Inter Pipeline is a medium-sized operator with almost all of its operations in Alberta, which is pretty friendly to pipelines. Its three main oil sands pipelines–which account for about 60% of revenue–are only running at about half capacity, which bodes well for whenever expansion starts up again in the region.

And, perhaps most importantly, Inter Pipeline pays an attractive 5.6% dividend, which comes with a payout ratio of approximately 70% of funds from operations.

Look deeper

Bay Street analysts spend much of their time covering companies that have market caps of over $1 billion, leaving the smaller companies for boutique investment houses to cover. Many investors ignore these smaller companies as a result.

These investors are making a mistake.

A study done in the United States looked at the performance of small-cap value stocks between 1926 and 2004. It found that smaller companies trounced the return of their larger counterparts, returning 15.6% annually compared to 9.3%.

There’s one big reason why Bay Street ignores these smaller companies. They’re just not profitable for bankers. Small-caps don’t really need to access the capital markets. And if they do, they’re raising less than $100 million. Large-caps often need billions at a time. Thus, they’ll get all the love.

Speaking of biases…

How come you hardly ever see an analyst slap a sell rating on a stock?

The answer might surprise you. It’s because of banking relationships–not because analysts are inherently bullish.

Look at it this way.

If you ran a company that needed to go to the capital markets for millions or even billions worth of financing, would you go to the bank that just downgraded your stock? I sure wouldn’t.

This is one of the reasons why no Bay Street analyst saw the Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) debacle coming. Even if an analyst did see accounting shenanigans, there’s no way they would say so publicly. Doing so would likely be dangerous to their job and the investment banking relationship.

Smart investing will always win

There’s a simple way to beat Bay Street at its own game. All you need to do is buy quality stocks when they’re valued well and hold them for a very long time. That’s how Warren Buffett did it–the original master at sticking it to bankers.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »